Gelesis® releases preliminary national launch results for plenity®: record-breaking levels of prescriptions and online traffic

Boston--(business wire)---- $gls--gelesis (nyse: gls), the maker of plenity, announced preliminary results from its broad awareness media campaign that debuted january 31, 2022. within the first three weeks, the company saw a 3-fold increase in web traffic and 3.5-fold increase in the number of individuals seeking a new prescription compared to previous months when supply was limited. gelesis anticipates that its 2022 net product revenue will be approximately $58 million in its first year of full launch
GLS Ratings Summary
GLS Quant Ranking